This brand name is authorized in Australia, Ecuador, Hong Kong SAR China.
The drug OPTIVE contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
K679OBS311 - CARBOXYMETHYLCELLULOSE SODIUM, UNSPECIFIED
|
|
Carmellose sodium has no pharmacological effect. Carmellose sodium has a high viscosity resulting in an increased retention time on the eye. |
|
2
|
UNII
PDC6A3C0OX - GLYCERIN
|
|
Glycerol has uses as a hyperosmotic, osmotic diuretic, and ophthalmic agent. It may be used as an eye drop in the treatment of glaucoma to reduce intraocular pressure, as a solution or suppository for short-term treatment of constipation, to evacuate the bowel prior to a colonoscopy, and in some ocular surgeries. It may be given intravenously to reduce pressure inside the brain and used externally on the skin as a moisturizer. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| S01XA20 | Artificial tears and other indifferent preparations | S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 5556K, 9355J, 9356K |
| EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | 28770-03-09, 5016-MEE-0320 |
| HK | Department of Health Drug Office | 57101, 61663, 63200 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.